October 18, 2012
SOUTH EASTON, Mass., -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that two research groups have reported on the ability of the Company's Pressure Cycling Technology ("PCT") Platform to improve the detection of DNA in challenging forensic samples. The studies were presented by scientists from the Institute of Applied Genetics, Department [...]
The University of Manchester Moves into the 4th Dimension
October 18, 2012
PLEASANTON, CA, – Xradia, Inc., the world's leading manufacturer of 3D X-ray microscopes for the lab and synchrotron, announced today that The University of Manchester has purchased the VersaXRM-500 3D X-ray microscope with funding from The Engineering and Physical Science Research Council for use in its advanced imaging laboratory. Manchester selected the XRM to better [...]
GnuBIO Promotes Susie Truong Harborth to Key Role as Chief Financial Officer
October 18, 2012
CAMBRIDGE, Mass -- GnuBIO, Inc., a pioneer in desktop DNA sequencing, today announced that Susie Truong Harborth has been promoted to Chief Financial Officer. Ms. Harborth has been with GnuBIO, www.gnubio.com since the company’s inception and will continue to lead finance, human resources and operations of the company while taking on new responsibilities for company [...]
Complete Genomics Announces Court’s Favorable Ruling in Patent Litigation Against Illumina, Inc.
October 18, 2012
MOUNTAIN VIEW, Calif., -- Complete Genomics, Inc. (Nasdaq:GNOM) today announced that Magistrate Judge Elizabeth D. Laporte of the U.S. District Court for the Northern District of California issued an Order granting Complete's Motion for Partial Summary Judgment of invalidity in the patent infringement lawsuit filed against Complete by Illumina, Inc. In that lawsuit, filed in [...]
October 18, 2012
BERLIN, --caprotec bioanalytics GmbH announced today a restructuring of its senior management and the appointment of Dr. Jonathan Turner as Managing Director and Chief Executive Officer. Dr. Turner joins caprotec as a highly regarded pharmaceutical executive and has held a number of senior management positions at global pharmaceutical companies, including Boehringer Ingelheim, AstraZeneca PLC and [...]
llumina Comments on a Ruling in its Patent Litigation Against Complete Genomics, Inc.
October 18, 2012
SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) announced today that Magistrate Judge Elizabeth D. LaPorte of the U.S. District Court for the Northern District of California granted a motion for summary judgment of invalidity filed by Complete Genomics, Inc. against certain claims of Illumina's U.S. Patent No. 6,306,597. Over Illumina's objections, the Court found that [...]
Grace Announces Additional Patent Notices of Allowance for Flash Chromatography Technology
October 18, 2012
Columbia, MD –- W. R. Grace & Co. (NYSE: GRA) announced today that the U.S. Patent and Trademark Office has granted three additional Notices of Allowance related to the company’s Reveleris® flash chromatography system. The benefits derived from these allowed claims enable streamlined purification of new chemical/biological entities for drug discovery. These notices describe actively [...]
HTG Molecular Diagnostics Introduces the EDGE System at AMP Conference
October 18, 2012
TUCSON, Ariz. – HTG Molecular Diagnostics will unveil the EDGE system at the AMP conference in Long Beach, October 25 – 27, 2012. The EDGE system is the first fully-automated instrumentation designed for clinical and research laboratories that offers nucleic acid extraction-free gene expression results from FFPE tissue and a variety of other sample types. [...]
October 18, 2012
SAN DIEGO, -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced that the California Technology Assessment Forum completed an independent evaluation of the cell-free fetal DNA technology used in the Sequenom Center for Molecular Medicine's (Sequenom CMM) MaterniT21 PLUS™ laboratory-developed test (LDT). CTAF recommended that [...]
iCyt Mission Technology Renamed Sony Biotechnology
October 18, 2012
New York -- iCyt Mission Technology, Inc., a wholly-owned subsidiary of Sony Corporation of America (SCA) and an active and long-time innovator in the flow cytometry industry, has changed its name to Sony Biotechnology Inc. (Sony Biotechnology). Under its new name, Sony Biotechnology will continue to develop, manufacture, sell, market, service and distribute high-quality cell [...]
